Related references
Note: Only part of the references are listed.Neuroblastoma: clinical and biological approach to risk stratification and treatment
Vanessa P. Tolbert et al.
CELL AND TISSUE RESEARCH (2018)
Prognostic significance of pattern and burden of metastatic disease in patients with stage 4 neuroblastoma: A study from the International Neuroblastoma Risk Group database
Daniel A. Morgenstern et al.
EUROPEAN JOURNAL OF CANCER (2016)
Improving Detection of Metastatic Neuroblastoma in Bone Marrow Core Biopsies: A Proposed Immunohistochemical Approach
Lauren N. Parsons et al.
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY (2016)
Neuroblastoma
Katherine K. Matthay et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Metastatic Neuroblastoma Confined to Distant Lymph Nodes (stage 4N) Predicts Outcome in Patients With Stage 4 Disease: A Study From the International Neuroblastoma Risk Group Database
Daniel A. Morgenstern et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Contribution of Multiparameter Flow Cytometry Immunophenotyping to the Diagnostic Screening and Classification of Pediatric Cancer
Cristiane S. Ferreira-Facio et al.
PLOS ONE (2013)
Medical Progress: Recent Advances in Neuroblastoma.
John M. Maris
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force
K. Beiske et al.
BRITISH JOURNAL OF CANCER (2009)
The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report
Tom Monclair et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
Susan L. Cohn et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Detection of GD2-positive cells in bone marrow samples and survival of patients with localised neuroblastoma
M. V. Corrias et al.
BRITISH JOURNAL OF CANCER (2008)
Lacking immunocytological GD2 expression in neuroblastoma: Report of three cases
R Schumacher-Kuckelkorn et al.
PEDIATRIC BLOOD & CANCER (2005)
Detection of residual neuroblastoma cells in bone marrow:: Comparison of flow cytometry with immunocytochemistry
K Swerts et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2004)
Detection of disseminated tumor cells in neuroblastoma -: 3 log improvement in sensitivity by automatic immunofluorescence plus FISH (AIPF) analysis compared with classical bone marrow cytology
G Méhes et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Flow cytometric immunophenotyping test for staging/monitoring neuroblastoma patients
MJ Warzynski et al.
CYTOMETRY (2002)
A new sensitive and specific combination of CD81/CD56/CD45 monoclonal antibodies for detecting circulating neuroblastoma cells in peripheral blood using flow cytometry
J Nagai et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2000)
Share Paper
